← Back to patent-cliff list
Indinavir Sulfate
Tier C — Watch / tradeIndinavir Sulfate
MSD (Merck Sharp & Dohme)
Originator
1996
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：HIV-1 protease
Brand：Crixivan
Indications (approved)：HIV infection
Regional status
US
Withdrawn
EU
Withdrawn
China
Approved
2002-03-05
Japan
Approved
1997-03-28
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Indinavir Sulfate?
Approved indications include: HIV infection.
When does the Indinavir Sulfate patent expire?
No public expiry year is available for Indinavir Sulfate yet; this page updates once verified.
How do I get a quote for Indinavir Sulfate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-04